Bicara Therapeutics Inc.

Historical 13F Holders

Symbol
BCAX
CUSIP
055477103
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 055477103 since 12/18/2024, largest first.

Filer % of Class Filed
RA Capital Management, L.P. 13D/A
11.5% 3/2/2026
Event 2/26/2026
Invus Global Management, LLC 13G/A
9.6% 7/31/2025
Event 6/30/2025
Vestal Point Capital, LP 13G/A
8.3% 5/15/2026
Event 3/31/2026
Deep Track Capital, LP 13G/A
6.2% 5/15/2026
Event 3/31/2026
BlackRock, Inc. 13G 5.4% 7/27/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
Janus Henderson Group Ltd. 13G/A 4.8% 8/13/2026
Event 6/30/2026
Red Tree GP, LLC 13G/A
4.8% 5/8/2026
Event 3/31/2026
T. Rowe Price Investment Management, Inc. 13G/A 4.2% 10/7/2026
Event 9/30/2026
FMR LLC 13G/A
3.2% 5/6/2026
Event 3/31/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 173 69.3 M $1.26B
2026 Q2 176 69.8 M $2.07B
2026 Q1 147 68.9 M $1.35B
2025 Q4 140 57.3 M $963M
2025 Q3 116 50.2 M $790M
2025 Q2 107 51.2 M $475M
2025 Q1 94 48.6 M $634M
2024 Q4 85 46.7 M $814M
2024 Q3 70 36.4 M $928M